ASCO 2015 Report: New, less toxic, treatment emerges for difficult-to-treat breast cancer
by Bruce Sylvester: Investigators from the phase III PALOMA-3 trial report that treatment with the recently FDA-approved drug palbociclib more than doubled the time to cancer recurrence among… read more.